These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 16968722
1. Effect of peritoneal dialysis on renal morphology and function. Breborowicz A, Pawlaczyk K, Polubinska A, Górna K, Wieslander A, Carlsson O, Tam P, Wu G. Nephrol Dial Transplant; 2006 Dec; 21(12):3539-44. PubMed ID: 16968722 [Abstract] [Full Text] [Related]
2. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Zareie M, De Vriese AS, Hekking LH, ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J. Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671 [Abstract] [Full Text] [Related]
3. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats. Zareie M, Keuning ED, ter Wee PM, Beelen RH, van den Born J. Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385 [Abstract] [Full Text] [Related]
4. Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure. Müller-Krebs S, Kihm LP, Zeier B, Gross ML, Deppisch R, Wieslander A, Henle T, Penndorf I, Oh J, Reiser J, Nawroth PP, Zeier M, Schwenger V. Eur J Clin Invest; 2008 May; 38(5):296-305. PubMed ID: 18346151 [Abstract] [Full Text] [Related]
5. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients. van de Kerkhof J, Schalkwijk CG, Konings CJ, Cheriex EC, van der Sande FM, Scheffer PG, ter Wee PM, Leunissen KM, Kooman JP. Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349 [Abstract] [Full Text] [Related]
6. Influence of peritoneal dialysis on the progression of chronic renal failure. Wang T, Ye RG, Zhen ZH, Li HQ, Mai WY. Adv Perit Dial; 1995 Apr; 11():139-41. PubMed ID: 8534688 [Abstract] [Full Text] [Related]
7. Effectiveness of furosemide in patients on peritoneal dialysis. Flinn A, Ledger S, Blake P. CANNT J; 2006 Apr; 16(3):40-4. PubMed ID: 17061696 [Abstract] [Full Text] [Related]
8. Effect of iodinated contrast agents on residual renal function in PD patients. Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E. Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623 [Abstract] [Full Text] [Related]
9. Iron sucrose induced morphological and functional changes in the rat kidney. Breborowicz A, Polubinska A, Górna K, Breborowicz M, Oreopoulos DG. Transl Res; 2006 Nov; 148(5):257-62. PubMed ID: 17145571 [Abstract] [Full Text] [Related]
10. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Zareie M, Keuning ED, ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J. Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741 [Abstract] [Full Text] [Related]
11. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 Jan; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
12. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH. Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384 [Abstract] [Full Text] [Related]
13. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial. Szeto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, Law MC, Li PK. Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526 [Abstract] [Full Text] [Related]
14. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats. Styszynski A, Kwiatkowska B, Wieczorowska-Tobis K, Breborowicz A, Oreopoulos DG. Adv Perit Dial; 2003 Feb; 19():15-9. PubMed ID: 14763027 [Abstract] [Full Text] [Related]
15. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. Liu IM, Tzeng TF, Liou SS, Chang CJ. J Ethnopharmacol; 2009 Jul 15; 124(2):211-8. PubMed ID: 19397971 [Abstract] [Full Text] [Related]
16. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, Choi MJ, Kim IS, Park MS, Kim YJ, Kim YL. Ther Apher Dial; 2007 Feb 15; 11(1):56-64. PubMed ID: 17309576 [Abstract] [Full Text] [Related]
17. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation]. Li XY, Hei ZQ, Li SR, Shen N. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul 15; 19(7):386-9. PubMed ID: 17631701 [Abstract] [Full Text] [Related]
18. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression. Zheng M, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y. J Diabetes Complications; 2009 Jul 15; 23(2):124-9. PubMed ID: 18413206 [Abstract] [Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
20. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats. Breborowicz A, Połubinska A, Wu G, Tam P, Oreopoulos DG. Blood Purif; 2006 Nov 15; 24(3):274-81. PubMed ID: 16465047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]